Staged Custom, Intramedullary Antibiotic Spacers for Severe Segmental Bone Loss in Infected Total Hip Arthroplasty by Kamath, Atul F. et al.
SAGE-Hindawi Access to Research
Advances in Orthopedics
Volume 2011, Article ID 398954, 7 pages
doi:10.4061/2011/398954
Clinical Study
Staged Custom, Intramedullary Antibiotic Spacersfor Severe
SegmentalBoneLossinInfectedTotal Hip Arthroplasty
AtulF. Kamath,1 OkechukwuAnakwenze,1 Gwo-ChinLee,2 and Charles L. Nelson3
1Department of Orthopaedic Surgery, University of Pennsylvania, 3400 Spruce Street, 2 Silverstein, Philadelphia, PA 19104, USA
2Department of Orthopaedic Surgery, Penn Presbyterian Medical Center, Cupp 1, 39th and Market Streets, Philadelphia,
PA 19104, USA
3Department of Orthopaedic Surgery, Geisinger Medical Center, Danville, PA 17822, USA
Correspondence should be addressed to Atul F. Kamath, akamath@post.harvard.edu
Received 14 February 2011; Accepted 30 June 2011
Academic Editor: Neil P. Sheth
Copyright © 2011 Atul F. Kamath et al.ThisisanopenaccessarticledistributedundertheCreativeCommonsAttributionLicense,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Introduction. Total hip arthroplasty (THA) infections with severe bone loss pose signiﬁcant reconstructive challenges. We present
our experience with two-stage hip reimplantation using an intramedullary, antibiotic-impregnated nail. Methods. Three patients
with infected THA with severe proximal femoral bone loss (Mallory type IIIB or greater) were treated using a custom antibiotic
spacer. Clinical outcomes and any complications were recorded. Average followup was 49 months from ﬁnal reimplantation.
Results.Mean age at spacer placement (stage 1) was 53 years. The mean Harris Hip Score at ﬁnal followup was 80. Two patients had
asymptomatic heterotopic ossiﬁcation, and one patient had a 2 cm leg-length discrepancy. Conclusions. A custom intramedullary
nail antibiotic spacer is a reliable option in the staged management of the infected THA with severe proximal femoral bone loss.
Beneﬁts of this technique include limb salvage with maintenance of leg length, soft tissue tension, and functional status.
1.Introduction
Infection after total hip arthroplasty (THA) is a catastrophic
complication that can cause signiﬁcant pain and disability.
Multiple failed reconstructive attempts, chronic infection, or
trauma may result in signiﬁcant bone loss, which further
complicates reconstruction. Severe acetabular and proximal
femoral bone loss can compromise limb stability and present
signiﬁcant challenges to the reconstructive hip surgeon.
Two-stage reconstruction is the gold standard for treat-
ment of periprosthetic joint infections [1–6]. Alternative
management options include resection arthroplasty [7],
multiple staged debridements, fusion, one-stage reconstruc-
tion [8–10], amputation, or chronic suppression antibiotic
therapy.Ifadequatehostboneispresent,reconstructionwith
hostbonecanbedoneinthesettingofone-[11]ortwo-stage
[12] reconstruction. While two-stage reconstruction with
antibiotic spacers may be successful in eradicating infection
in up to 95% of patients [13–15], traditional reconstructive
techniques fall short in the face of segmental bone loss or
hostfactorsthatprecludeuseofhostboneforreconstruction
[16].
Custom devices substituting for severe segmental bone
loss after infected THA provide an opportunity at limb
salvage, with maintenance of leg length, soft tissue tension,
direct antibiotic elution into the tissue bed, and possibility
for improved functional status/ambulatory capacity. How-
ever, the manufacturing of these custom prostheses can be
costly and impractical. The purpose of this report is to
present a technique and clinical results, at greater than four-
year follow-up, for staged reconstruction of the infected
THA with severe proximal femoral bone loss using a custom
intramedullary antibiotic spacer.
2. Methods
We present three patients with infected hip prostheses
managed with a custom antibiotic cement spacer fabricated
out of a commercially available intramedullary nail. The
patients underwent resection arthroplasties of an infected2 Advances in Orthopedics
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Figure 1: Anterior-posterior (a) and lateral (b) views after multiple
prior revision attempts, demonstrating severe proximal femoral
bone loss, component subsidence and compromise of the cement
mantle, and perforation of the anterolateral femoral cortex of an
infected THA.
proximal femur replacement, a draining infected long-stem
PROSTALAC, and long-stem THA, respectively. All patients
had at least grade IIIB femoral defects according to the
Mallory classiﬁcation [17] or at least grade IIIA bone
loss according to the system proposed by Della Valle and
Paprosky [18] (Figures 1(a) and 1(b)). There were two males
and one female, with an average age of 53 years (range, 43–
61). All patients had multiple revisions prior to two-stage
reconstruction:twopatientshadfourpriorrevisions,andthe
other patient had three revision attempts.
A cephalomedullary nail (Gamma 3, Stryker, Mahwah,
NJ) was used with custom-molded antibiotic cement, fol-
lowing resection arthroplasty of the chronically infected
THA (Figures 2(a) and 2(b)). The acetabular portion of the
spacer mold was fashioned with the use of a bulb syringe
to serve as a template. All procedures from index THA to
ﬁnal reimplantation were reviewed. The type and course
of antibiotic regimens, inﬂammatory markers, clinical and
functional outcomes, range of motion, and any complica-
tions were recorded. Radiographs were reviewed for any
evidence of component loosening, subsidence, or fracture
(Figures 3(a) and 3(b)). Following resection arthroplasty, all
patients received culture-speciﬁc antibiotics for an averageof
15 weeks (range, 6–28).
(a)
(b)
Figure 2: Anterior-posterior (a) and lateral (b) views after resec-
tion of infected THA and placement of a custom, antibiotic-
impregnated cement intramedullary nail spacer.
3. CaseStudy
A 42-year-old man presented to our clinic for tertiary
care consultation. He had undergone a THA seven years
earlier for posttraumatic arthritis. His past medical history
was signiﬁcant for hepatitis C infection requiring liver
transplantation in 1999, now maintained on cyclosporine
immunosuppression. The index arthroplasty operation had
been complicated by early loosening, necessitating revision
surgery performed in his home country of Puerto Rico. On
presentation, he complained of groin pain with hip internal
rotation and thigh pain. Radiographs revealed a hybrid total
hipimplantwithevidenceofcircumferentiallooseningabout
the femoral stem and proximal femoral osteopenia.
The patient underwent revision of both acetabular and
femoral components with trochanteric plate stabilization
and impaction grafting. On initial postoperative visit, the
femoral stem was noted to have perforated the thinned
femoral cortex. The decision was made to revise his femur
with removal of the implant and plate ﬁxation of the femur
with a long distal femoral plate to allow support at the
fracturesite.Unfortunately,hesuﬀeredafractureatthepoint
of high stress between the trochanteric plate and the distal
femur plate.
At this point, eight months from initial presentation, he
optedforaone-stagesurgicalsalvageprocedure.Considering
the extent of bone loss and poor structural strength, a tumorAdvances in Orthopedics 3
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Figure 3: Anterior-posterior (a) and lateral (b) views of the femur
after extraction of custom intramedullary nail spacer and deﬁnitive
reconstruction with long-stem cemented THA prosthesis.
style prosthesis was believed to provide the most predictable
and reliable surgical option. Therefore a proximal femur
replacement (Stryker, Mahwah, NJ, USA) was performed
without complication.
The patient returned to his home country and did well
for a year. However, he did not limit his activity after
his last reconstruction and suﬀered two dislocation events.
The ﬁrst dislocation event was treated closed. However,
the second incident required open reduction, which was
performed in Puerto Rico. He then returned to our clinic,
six months after his last dislocation and two years since
reconstruction. He complained of hip pain and swelling
about the scar region. A positron emission tomography scan
was performed and revealed high uptake about the implant
and surrounding tissues. Erythrocyte sedimentation rate and
CRP were 35mm/hr and 2.3mg/dL, respectively. The clinical
presentation, PET scan, and inﬂammatory markers were
highly suggestive of periprosthetic infection.
The patient elected for two-stage reimplantation and
underwent initial resection arthroplasty of all components.
A Gamma 3 nail coated with antibiotic impregnated cement
was implanted as a spacer to provide stability in the presence
of signiﬁcant bone loss. Five packs of cement were used in
total, with 3.6 grams of tobramycin used per bag of cement.
Intraoperative cultures grew Staphylococcus epidermidis,a n d
he was placed on intravenous vancomycin. The patient
remained on intravenous antibiotic therapy for nine weeks,
with serial labs and clinical examinations. Twelve weeks
after spacer implantation, he underwent a second-stage
reconstruction with a proximal femoral replacement with
a constrained acetabular prosthesis (Zimmer, Warsaw, IN,
USA). Final intraoperative cultures and frozen sections were
negative.
At latest followup, 38 months after second-stage recon-
struction, he continued to do well. He was able to walk
comfortably with a cane and was able to sit comfortably for
over an hour. Hip ﬂexion was 100 degrees, extension to 10
degrees, abduction to 40 degrees, adduction to 40 degrees,
internal rotation to 20 degrees, and external rotation to 60
degrees. The latest Harris Hip Score was 77. Radiographs
at ﬁnal followup revealed a well-ﬁxed prosthesis with no
evidence of loosening.
4.SurgicalTechnique
Preoperative templating is essential to anticipate areas of
bone loss and to prepare for type of reconstructive implant
required. The hip is approached via a standard posterolateral
approachtothehip.Anextendedtrochantericosteotomycan
be performed in order to facilitate removal of the infected
femoral component and/or infected cement.
In cases in which acetabular bone stock is suﬃcient, the
use of a cephalomedullary nail coated with antibiotic cement
is an eﬀective way to manage patients with severe proximal
femoral bone loss. An intramedullary nail is used to form the
coreofthespacer.Preoperativetemplatingandtractionaided
leg-length measurements are used to determine the length of
the intramedullary nail required to achieve both axial and
rotational stability. The acetabular size is estimated from the
explanted hardware and intraoperative assessment following
removal of all necrotic and nonviable bone. The use of
hemiarthroplasty head sizers can be helpful in sizing and to
provide a template for fabrication of the antibiotic cement
acetabular ball head. Polymethylmethacrylate cement is
hand-mixed with high dose concentrations of vancomycin
and tobramycin (e.g., 3.6 grams of tobramycin per bag
of cement), and the nail is encapsulated with cement in
a custom-molded fashion. Once the cement is suﬃciently
doughy, it is molded around the nail to approximate the
shape of resected bone and explanted prosthesis. The custom
spacer is inserted into the canal when the cement is ﬁrm (but
not hard), and the construct is reduced into the acetabulum.
The limb is held at length and in the appropriate rotation
during the ﬁnal cement curing process. Usually, it is not
necessary to place distal interlocking screws through the
nail, however if rotational stability cannot be achieved, it
is an option, but later concern for creation of a stress riser
must be considered. Hardware placement is conﬁrmed with
intraoperative radiographs.
The hips in this study were reconstructed using the fol-
lowingimplants:oneproximalfemoralreplacementprosthe-
sis with a constrained acetabular component (Zimmer, War-
saw, IN, USA), one proximal femoral replacement prosthesis4 Advances in Orthopedics
with a constrained acetabular component (Stryker, Mah-
wah, NJ, USA), and one modular LINK cemented femoral
prosthesis (Waldemar Link, Hamburg, Germany). Tissue
cultures were obtained at time of stage 2 reimplantation, and
patients weremaintained on intravenous antibiotics pending
ﬁnal intraoperative culture results. No long-term suppressive
antibiotic regimens were used.
Postoperative rehabilitation included physical therapy
starting postoperative day one. Partial weight bearing was
allowed immediately, and ambulatory function and assistive
aids were advanced as tolerated. Abduction bracing was used
for prior history of dislocation.
5. Results
The mean age at initial spacer placement (stage 1) was 53
years(range,43to61years).AverageCharlsonCo-Morbidity
Index score was 2 (range, 1 to 3). Average BMI was 28 at
initial presentation (range, 27–31). There were two smokers
in the cohort. All patients had a traumatic etiology as a cause
for the index THA. Two patients had a contralateral THA in
placeatinitialpresentation.Twopatientshadbeendiagnosed
with osteopenia/osteoporosis over the course of the study
period. There were no active Worker’s Compensation claims
during the study. One patient had a history of substance
abuse.
The mean time between index THA and stage 1 proce-
dure was 6.9 years (range, 15 to 129 months). All patients
were ambulatory at time of initial presentation to our clinic
but used some form of assistive device (e.g., cane, walker).
Average ESR and CRP values prior to stage 1 procedure
were 42mm/hr and 5mg/dL, respectively. Average estimated
blood loss at stage 1 was 783cc (range, 300–2000). At
time of stage 1 explant/spacer placement, intraoperative cul-
tures conﬁrmed methicillin-resistant Staphylococcus aureus,
Staphylococcus epidermidis, and vancomycin-resistant Ente-
rococcus. The mean interval time between stage 1 procedure
and ﬁnal reimplantation (stage 2) was ﬁve months (range,
3–8). Average ESR and CRP prior to stage 2 procedures
were 22mm/hr and 1.0mg/dL, respectively. There were
no problems with extraction of the intramedullary spacer
devices at stage 2. The average estimated blood loss at stage 2
was 1100cc (range, 1000–1200).
Complications included development of mild (Brooker
Class II) heterotopic ossiﬁcation in two patients [19]. There
were no dislocations or fracture of the temporary spacers.
There were no recurrent infections. One patient had a leg-
length discrepancy of 2cm at ﬁnal evaluation. The mean
Harris Hip Score was 80 (range, 77–84) at time of ﬁnal
evaluation. Two patients were free of assistive devices, while
one patient used cane.
6. Discussion
We report a series of patients with severe segmental femoral
bone loss in the setting of periprosthetic hip infections
managed with staged, custom-made antibiotic spacers.
T h ea m o u n to fb o n el o s sw a st o oe x t e n s i v ef o rc o m -
mercially available spacers and challenged traditional hip
reconstruction algorithms, including previously described
custom uses of antibiotic spacers [20–25]. Our primary
research purpose was to deﬁne the clinical and functional
outcomes, including eradication of infection, after two-stage
reconstruction with custom-made spacers. The utility of
these spacers as bridging procedures to ultimate reimplan-
tation was of key interest.
The goals of two-stage reimplantation of infected THA
are to eradicate infection [26], to provide local and systemic
delivery of antibiotics at the infection site via the cement [27,
28], and to maintain the soft tissue envelope while awaiting
reconstruction [29, 30]. Allowing postoperative mobility
[31] is also essential to preventing complications associated
with bedrest. When bone loss is minimal, standard spacers
and commercially available devices are usually suﬃcient to
accomplish such goals of revision THA [32–35]. However,
when there is extensive bone loss in the proximal femur or
acetabulum, options become limited.
The standard PROSTALAC articulated spacer, or
other commercially available, prefabricated antibiotic-
impregnated monopolar prostheses, like the Spacer-G
(Tecres S.p.A, Verona, Italy) or antibiotic-loaded cement
hemiarthroplasty (ANTILOCH) prosthesis, can be used
eﬀectively when there is minimal bone loss for standard
reconstructions. However, these prostheses and techniques
are not designed for extensive proximal femoral bone loss
with little supporting host bone [36]. Severe segmental
femoral or acetabular bone loss is not amenable to these
reconstructive techniques. Commercially available or
prefabricated/molded products may incur higher costs (in
addition to cement costs) and may limit implant size choices
intraoperatively [37].
Other techniques for antibiotic delivery include antibi-
otic beads. The use of antibiotic beads has not been shown to
be superior to spacer prostheses implantation for restoration
of functional mobility in two-stage reconstruction [13].
While there is a theoretical greater surface area for elution
with beads [30], Tonegawa et al. found no long-term elution
rate diﬀerence between beads and spacers with the use of
gentamicin [38]. Limited use of antibiotic cement, such as
antibiotic screws for infected intramedullary nailing [39],
does not provide opportunity for adequate debridement,
antibiotic delivery, and functional stability.
Kirschner-wire [30], Rush pin [40], or other modiﬁed
custom-spacertechniques[25,41]ma ynotpr o videadequat e
strength, stability, or length to compensate for severe loss of
bone stock. For example, periprosthetic fracture has been
seen with the use of Kirschner-wire cemented spacers [30].
Hand-molded cement implants placed into areas of the
proximal femoral metaphysis, even if reinforced with plates
and/or screws, have been complicated by dislocations and
componentfracture[25].Similarcementprosthesisfractures
o rd i s l o c a t i o n sh a v eb e e ns e e ni no t h e rs t u d i e s[ 7, 32].
While Hsieh et al. successfully incorporated structural
allograft in the second stage of reconstruction for massive
femoral bone loss, there were two fractures and one dislo-
cation of the custom-made interim antibiotic spacer [36].
Loty et al. and Rudelli et al. used allograft material in one-
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may have an unacceptably high infection rate, especially after
prior failed reconstruction attempts [8]. Using antibiotic-
impregnated allograft in one-stage revisions, Winkler et al.
found a 92% infection-free rate at a mean of 4.4 years
followup [44].
While antibiotic spacers have been demonstrated to be
safe, there are potential systemic side eﬀects [29, 45], which
were not seen in our patient cohort. Moreover, there have
been concerns with antibiotic resistance to cement-laden
spacers in vivo [46]. With the emergence of multidrug
resistantorganismsandtheprojectedincreaseintheabsolute
number of primary and revision arthroplasty procedures
[30, 47], the number and complexity of periprosthetic
infections will challenge future reconstruction algorithms.
Other questions remain, such as the need, if any, and
the duration of suppressive antibiotic treatment after ﬁnal
reconstruction stage [48].
There are limitations to this study. The relatively rare
indications for use of the custom temporary spacers resulted
inasmallpatientcohort.Therewasnocontrolgrouptocom-
pare more traditional reconstructive or alternative custom-
made spacer techniques. The surgical technique described
may be applicable to tertiary care referral centers that
regularly manage complex revision arthroplasty patients:
there is a learning curve: the surgeon must be comfortable
with the reconstructive options available and any potential
perioperative complications, and the necessary support staﬀ
and resources must be readily available.
To our knowledge, no study reports a series of full-
length intramedullary nails with custom-molded antibiotic
cement in the management of this complex reconstructive
problem. One case report describes the use of an antibiotic-
coated short-length cephalomedullary nail for treatment
of an infected femoral intertrochanteric nonunion after
compression hip screw placement [49]; no followup beyond
18 months is available for this patient. A case report has
been presented on the use of a long-stem femoral prosthesis
in the two-stage reconstruction of an infected THA with
periprosthetic fracture [50].
7. Conclusions
We present a novel method of antibiotic delivery and limb
stabilization during two-stage reconstruction of the infected
THA. The technique, with greater than four years’ followup,
is a viable alternative to previously described treatment
modalities.
Placement of custom devices substituting for severe
segmental bone loss oﬀers a reliable option in the staged
management of the infected THA. Importantly, it provides
an opportunity at limb salvage with maintenance of leg
length, soft tissue tension, and functional status.
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